Skip to main content

Table 4 NOD2 and LCT mutation distribution in MAP infected and non-infected individuals among Crohn’s disease (CD), ulcerative colitis (UC) and in control (HC) cohorts [ n (%)]

From: Lactase persistence, NOD2 status and Mycobacterium avium subsp. paratuberculosis infection associations to Inflammatory Bowel Disease

Number of mutations CD (n = 173) UC (n = 105) HC (n = 188)
  MAP + MAP - MAP + MAP - MAP + MAP -
NOD2
0 29 (16.76) 103 (59.54) 19 (18.10) 77 (40.96) 77 (40.96) 87 (46.28)
1 7 (4.05) 26 (15.03) 1 (0.95) 7 (6.67) 8 (4.26) 16 (8.51)
2 1 (0.58) 7 (4.05) 0 (0.00) 1 (0.95) 0 (0.0) 0 (0.00)
LCT
0 27 (15.61) 109 (63.01) 14 (13.33) 64 (60.95) 73 (38.83) 80 (42.55)
1 10 (5.78) 27 (15.61) 6 (5.71) 21 (20.00) 12 (6.38) 23 (12.23)
  1. No significant differences were detected among groups except for CD versus HC NOD2 0 and CD versus HC LCT 0 (p < 0.0001).